Johan Askling
Professor/senior physician
I am a professor of rheumatology / rheumatic disease epidemiology at Karolinska Institutet, and a senior consultant rheumatologist at the Karolinska University Hospital
Research description
Selected publications
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment? Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, et al Arthritis Rheum. 2009 Nov;60(11):3180-9
Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. Holmqvist ME, Neovius M, Eriksson J, Mantel Ä, Wållberg-Jonsson S, Jacobsson LT, et al JAMA 2012 Oct;308(13):1350-6
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden. Raaschou P, Simard JF, Holmqvist M, Askling J, BMJ 2013 Apr;346():f1939
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis. Ljung L, Simard JF, Jacobsson L, Rantapää-Dahlqvist S, Askling J, Arthritis Rheum. 2012 Jan;64(1):42-52
Swedish registers to examine drug safety and clinical issues in RA. Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N, et al Ann. Rheum. Dis. 2006 Jun;65(6):707-12
Education
PhD, Karolinska Institutet
MD, Uppsala University